ADVIA CENTAUR MYOGLOBIN (MYO) 09011232

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2009-03-04 for ADVIA CENTAUR MYOGLOBIN (MYO) 09011232 manufactured by Siemens Healthcare Diagnostics Inc..

Event Text Entries

[15700603] Two falsely suppressed advia centaur myoglobin results were obtained on pt samples. Repeat testing was performed on the pt samples and the test results were higher. The second pt sample was tested on the advia centaur cp and the result was much higher than the repeat on the advia centaur. Pt treatment was not prescribed or altered. There was no report of adverse health consequences due to the discordant myoglobin results.
Patient Sequence No: 1, Text Type: D, B5


[15985907] A siemens field service engineer (fse) was sent to the customer site. Analysis of the instrument and instrument data indicated that the sample probe vertical pulley needed adjustment. The fse readjusted and tightened the vertical pulley and recalibrated the sample probe. The instrument is performing within specifications. No further eval of the device is required.
Patient Sequence No: 1, Text Type: N, H10


[15840511] Two falsely suppressed advia centaur myoglobin results were obtained on pt samples. Repeat testing was performed on the pt samples and the test results were higher. The second pt sample was tested on the advia centaur cp and the result was much higher than the repeat on the advia centaur. Pt treatment was not prescribed or altered. There was no report of adverse health consequences due to the discordant myoglobin results.
Patient Sequence No: 2, Text Type: D, B5


[16139355] A siemens field service engineer (fse) was sent to the customer site. Analysis of the instrument and vertical pulley needed adjustment. The fse readjusted and tightened the vertical pulley and recalibrated the sample probe. The instrument is performing within specifications. No further eval of the device is required.
Patient Sequence No: 2, Text Type: N, H10


MAUDE Entry Details

Report Number1219913-2009-00022
MDR Report Key1334966
Report Source05,06
Date Received2009-03-04
Date of Report2009-02-17
Date of Event2009-02-17
Date Mfgr Received2009-02-17
Date Added to Maude2010-08-21
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactEIMAN SULIEMAN
Manufacturer Street333 CONEY ST.
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604603
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY ST.
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Remedial ActionOT
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR MYOGLOBIN (MYO)
Generic NameMYOGLOBIN IMMUNOASSAY
Product CodeDDR
Date Received2009-03-04
Model NumberNA
Catalog Number09011232
Lot Number055160
ID NumberNA
Device Expiration Date2009-11-24
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeNA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS INC.
Manufacturer AddressTARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2009-03-04
20 2009-03-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.